1206774-53-9Relevant academic research and scientific papers
HETEROCYCLIC ANTIVIRAL COMPOUNDS
-
Page/Page column 40, (2010/04/25)
Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
HETEROCYCLIC ANTIVIRAL COMPOUNDS
-
Page/Page column 45, (2010/11/05)
Compounds having the formula I wherein R1, R2, R3, R4, R5a, R5b, R5c and R6 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are
HETEROCYCLIC ANTIVIRAL COMPOUNDS
-
Page/Page column 28, (2010/12/29)
Compounds having the formula I wherein wherein R1, R2, R3b, R4a, R4b, R4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods
Heterocyclic antiviral compounds
-
, (2010/02/17)
Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
